更正：加速流感研究：疫苗、抗病毒药物、免疫调节剂和单克隆抗体。用于人类病毒挑战模型的新型野生型H3N2病毒的制造。

1

PLoS One. 2016 Jun 9;11(6):e0157211. doi: 10.1371/journal.pone.0157211. eCollection 2016.

2

PLoS One. 2018 Dec 27;13(12):e0210043. doi: 10.1371/journal.pone.0210043. eCollection 2018.

3

PLoS One. 2016 Sep 22;11(9):e0163830. doi: 10.1371/journal.pone.0163830. eCollection 2016.

4

Vaccine. 2015 May 11;33(20):2360-6. doi: 10.1016/j.vaccine.2015.03.031. Epub 2015 Mar 21.

5

Vaccine. 2014 Jan 23;32(5):535-43. doi: 10.1016/j.vaccine.2013.12.002. Epub 2013 Dec 14.

6

Antimicrob Agents Chemother. 2015 May;59(5):2647-53. doi: 10.1128/AAC.00118-15. Epub 2015 Feb 17.

7

Arch Virol. 2002 Nov;147(11):2125-41. doi: 10.1007/s00705-002-0870-y.

8

PLoS One. 2017 Dec 5;12(12):e0189384. doi: 10.1371/journal.pone.0189384. eCollection 2017.

9

MMWR Morb Mortal Wkly Rep. 2012 Apr 13;61(14):237-41.

10

Vaccine. 2014 Sep 29;32(43):5730-9. doi: 10.1016/j.vaccine.2014.08.029. Epub 2014 Aug 27.

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.